Langford C A
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Best Pract Res Clin Rheumatol. 2001 Jun;15(2):281-97. doi: 10.1053/berh.2001.0144.
The systemic vasculitides are a wide-ranging group of diseases that are characterized by the presence of blood vessel inflammation. Despite this common feature, each type of vasculitis has a unique variety of clinical manifestations that influences its degree of disease severity and ultimately its management. Immunosuppressive therapy forms the foundation of treatment for almost all forms of systemic vasculitis. Because of this, treatment can be associated with its own risk of morbidity, or even mortality, related to specific medication side-effects or infections which occur as a result of impaired host defences. This chapter seeks to review the approach to management in selected forms of systemic vasculitis. Questions examined include the following. When should one treat systemic vasculitis? How does the nature of the disease and its severity affect treatment decisions? What are the data regarding the effectiveness of individual therapeutic regimens?
系统性血管炎是一大类以血管炎症为特征的疾病。尽管有这一共同特征,但每种类型的血管炎都有独特的临床表现,这些表现会影响其疾病严重程度,最终影响其治疗。免疫抑制疗法是几乎所有形式的系统性血管炎治疗的基础。因此,治疗可能会因其自身的发病风险,甚至死亡风险而受到影响,这些风险与特定药物副作用或因宿主防御功能受损而发生的感染有关。本章旨在回顾某些形式的系统性血管炎的管理方法。探讨的问题包括以下几点。何时应该治疗系统性血管炎?疾病的性质及其严重程度如何影响治疗决策?关于个别治疗方案有效性的数据有哪些?